Medical devices, healthcare technology and the business of care
510(k) clearance · K263319

ACHM30 AtriClip FLEX-Mini LAA Exclusion System

AtriCure, Inc. · Decision date Oct 21, 2026

MEDTECHLEDGER EXPLANATIONK263319

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 10/21/2026 for K263319, the ACHM30 AtriClip FLEX-Mini LAA Exclusion System, submitted by AtriCure, Inc. of Mason, Ohio. The application was received 09/21/2026 and reviewed under regulation 878.4300, classification name Left Atrial Appendage Clip, Implantable, with product code PZX and subsequent product code FZX. The regulation medical specialty is listed as General & Plastic Surgery, and the review panel as Cardiovascular. SESE denotes 510(k) clearance, not premarket approval.

The record describes the submission type as Special, with no third-party review, no combination product status and no authorized predetermined change control plan. The page does not state which components or modifications distinguish this device from its predicate, nor does it include a summary statement, so the basis for the equivalence finding and any labeling or indication details remain unknown from this source.

The listed decision date is 10/21/2026, and the page shows a last-updated date of 10/26/2026. No clinical, efficacy or patient-selection conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Oct 21, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263319
Regulatory pathway
510(k) premarket notification
Product code
PZX
Decision code
SESE
Decision date
Oct 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Left Atrial Appendage Clip, Implantable.

Product code
PZX
FDA device class
2

FDA decision timeline

  1. K263319 received

    Application receipt date recorded by FDA.

  2. K263319 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

AtriCure, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Mason, OH

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records